Cite

HARVARD Citation

    Lewis, J. et al. (n.d.). Outcomes for platinum doublet chemotherapy before and after first-line immune checkpoint inhibition in advanced non-small cell lung cancer (NSCLC). Lung cancer. pp. S34-. [Online]. 
  
Back to record